T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival

BACKGROUND: In HER2-overexpressing breast cancer, accumulating preclinical evidences suggest that some chemotherapies, like trastuzumab, but also taxanes, are able to trigger a T helper 1 (Th1) anticancer immune response that contribute to treatment success. T helper 1 immune response is characteris...

詳細記述

保存先:
書誌詳細
主要な著者: Ladoire, S, Arnould, L, Mignot, G, Apetoh, L, Rébé, C, Martin, F, Fumoleau, P, Coudert, B, Ghiringhelli, F
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2011
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172914/
https://ncbi.nlm.nih.gov/pubmed/21750556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.261
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料